PT  - JOURNAL ARTICLE
AU  - Jennifer Hadam
AU  - Elie Aoun
AU  - Kofi Clarke
AU  - Mary Chester Wasko
TI  - Managing risks of TNF inhibitors: An update for the internist
AID  - 10.3949/ccjm.81a.12121
DP  - 2014 Feb 01
TA  - Cleveland Clinic Journal of Medicine
PG  - 115--127
VI  - 81
IP  - 2
4099  - http://www.ccjm.org/content/81/2/115.short
4100  - http://www.ccjm.org/content/81/2/115.full
SO  - Cleve Clin J Med2014 Feb 01; 81
AB  - Tumor necrosis factor (TNF) inhibitors have many beneficial effects, but they also pose infrequent but significant risks, including serious infection and malignancy. These risks can be minimized by judicious patient selection, appropriate screening, careful monitoring during treatment, and close communication between primary care physicians and subspecialists.